L Kennedy, WH Herman, P Strange, A Harris - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The Glycemic Optimization with Algorithms and Labs
at Point of Care (GOAL A1C) study was a 24-week, randomized, parallel-group,
four-arm, open-label study of 7,893 adults with type 2 diabetes ... Cited by 3 - Related articles - All 2 versions
- Free from Publisher JR Petersen, JB Finley, AO Okorodudu, AA … - Diabetes care, 2007 - Am Diabetes Assoc Although most diabetes management guidelines (1–3) suggest that physicians
measure A1C, it is extremely difficult to have results available before a
physician's evaluation of the patient. As such, point-of-care (POC) A1C is ... Cited by 3 - Related articles - BL Direct - All 5 versions
- Free from Publisher L Kennedy, WH Herman, P Strange, A Harris … - Diabetes care, 2006 - ncbi.nlm.nih.gov OBJECTIVE: The objective of this study was to assess the impact of active versus
usual monitoring of algorithmic insulin titration and point-of-care (POC) versus
laboratory HbA1c (A1C) measurement on glycemic control in primary care. ... Cited by 23 - Related articles - BL Direct - All 5 versions
- ►umich.edu [PDF] L Kennedy, WH Herman - Diabetes Technology & Therapeutics, 2005 - liebertonline.com 1 and WILLIAM H. HERMAN, MD, MPH ... Background: The Glycemic Optimization with
Algorithms and Labs At Po1nt of Care (GOAL A1C) Study assessed the effect of
titration monitoring strategies and methods of A1C testing on glycemic ... Cited by 11 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org JB Brown, SB Harris, S Webster-Bogaert, S … - Diabetes Spectrum, 2004 - Am Diabetes Assoc Diabetes is a multisystem disease requiring complex management provided by a
variety health care professionals (HCPs). Comprehensive care of patients with
diabetes requires frequent testing of hemoglobin A 1c (A1C), and research ... Cited by 6 - Related articles - BL Direct - All 2 versions
- ►nih.gov [PDF] E Byrne, G Savage, JD Merrett, L Kennedy - The Ulster Medical Journal, 1984 - pubmedcentral.nih.gov FOLLOWING the introduction of insulin therapy in 1922 one of the major problems
in the long-term management of insulin-dependent diabetes was the lack of a
convenient, reliable and objective test of longer term glycaemic control. ... Cited by 5 - Related articles - All 3 versions
- ►diabetesjournals.org L Kennedy, WH Herman - Diabetes care, 2005 - Am Diabetes Assoc Metformin use has been associated with lactic acidosis, a rare but potentially
lethal condition characterized by elevated blood lactate levels (>5 mmol/l), an
increased lactate-to-pyruvate ratio, and an increased anion gap (1). Most ... Cited by 5 - Related articles - All 5 versions
DA Sicard, JR Taylor - The Annals of pharmacotherapy, 2005 - Harvey Whitney Books METHODS: Twenty-three patients who had type 1 or 2 diabetes were identified from
our pharmacy-run diabetes clinic at a primary care clinic as needing HbA 1c
evaluation based on the American Diabetes Association guidelines. All ... Cited by 9 - Related articles - All 4 versions
JR Petersen, JB Finley, AO Okorodudu, AA … - Point of Care, 2008 - journals.lww.com Using hemoglobin A 1c (HbA 1c ) levels as an indicator of quality of care, we
assessed the impact that the availability of point-of-care (POC) HbA 1c had on
patient care in a diabetic care clinic. This was a retrospective ... Related articles
RY Macías, LCHRUCH Málaga - web-sanac.org La Hemoglobina A1 es la hemoglobina modificada por la adición de glucosa en el
residuo N- terminal de las cadenas de globinas α y/o β de la hemoglobina A.
Esta reacción es lenta y no enzimática. La Hb A1 está formada por tres ... Related articles - View as HTML
